Clinical Trial Results:
A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum in Patients with Allergic Rhinitis and/or Rhinoconjunctivitis with or without Intermittent Asthma
Summary
|
|
EudraCT number |
2012-000416-28 |
Trial protocol |
DE ES CZ PL |
Global completion date |
29 Apr 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 May 2018
|
First version publication date |
10 May 2018
|
Other versions |
|
Summary report(s) |
6043-PG-PSC-192_summary 6043-PG-PSC-192_lay man summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.